Loading
A life-science venture capital firm with offices in Shanghai, Hong Kong and Palo Alto. It began in 2008 as a venture arm of the drug company Eli Lilly and became independent in 2011.
LAV describes itself as a biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong and Palo Alto, investing in biopharmaceuticals, human therapeutics, medical devices and diagnostics (LAV website). It states that it originated in 2008 as a corporate venture subsidiary of Eli Lilly and spun off in 2011 to become an independent investment management company (LAV, About us).
No OnCo company names this investor yet. Portfolio links are declared on the startup record (`investors`), so adding one there lists it here.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/